Fibrinogen and its relations to subclinical extracoronary and coronary atherosclerosis in hypercholesterolemic men

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 1, 1997, Pages 45-50

  Levenson, Jaime ^a   Giral, Philippe ^a   Megnien, Jean Louis ^a   Gariepy, Jérome ^a   Plainfosse, Marie Christine ^a   Simon, Alain ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

B mode ultrasonography; coronary atherosclerosis; extracoronary atherosclerosis; fibrinogen; ultrafast computed tomography

Indexed keywords

CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AORTA ATHEROSCLEROSIS; ARTERY CALCIFICATION; ARTICLE; ATHEROGENESIS; B SCAN; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; ECHOCARDIOGRAPHY; FEMORAL ARTERY; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031035852     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.1.45     Document Type: Article

References (9)

1. Giral P, Pithois-Merli I, Filitti V, Levenson J, Plainfosse MC, Mainardi C, Simon A, and the PCVMETRA Group. Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men. Arch Intern Med. 1991;151:950-956.
2. Wilhelmsen L, Svardsudd K, Korsan-Bengsten K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;31:501-505.
3. Stone MC, Thorp JM. Plasma fibrinogen: a major coronary risk factor. J R Coll Gen Pract. 1985;35:565-569.
4. Balleisen L, Bailey J, Epping PH, Schulte H, Van De Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population, I: baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost. 1985;52:475-479.
5. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Sterling Y, Imeson SD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
6. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA. 1987;258:1183-1186.
7. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity and white blood cell count are major risk factors for ischaemic heart disease: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation. 1991;83:836-844.
8. Lowe GDO, Fowkes FGR, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation. 1993;87:1915-1920.
9. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993;118:956-963.